Sars 1 Antibody Test
Lab Reagents
Human IgG antibody Laboratories manufactures the sars 1 antibody test reagents distributed by Genprice. The Sars 1 Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: 1 Group: Antibody Test
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
3CL Protease (SARS-CoV-2) |
|||
100823-1 | BPS Bioscience | 50 µg | EUR 400 |
Description: Severe acute respiratory Coronavirus 2 3C-like protease (SARS-CoV-2 3CL Protease), GenBank Accession No. YP_009725301, a.a. 1-306(full length), expressed in an E. coli expression system, MW=34 kDa. |
Spike (SARS-CoV-2) Lentivirus |
|||
78010-1 | BPS Bioscience | 100 µl | EUR 835 |
Description: Cell entry of SARS-CoV-2 depends on the binding of viral spike protein to cellular receptor ACE2. The SARS-CoV-2 Spike Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. The particles contain the full length SARS-CoV-2 spike gene (QHD43416.1) driven by an EF1a promoter._x000D_ |
Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Colloidal gold immunoassay) |
|||
CP04010 | UnScience | 25T/kit | Ask for price |
Description: The Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Serum/Plasma/Whole blood) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 neutralizing antibodies in serum, plasma and whole blood. The sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 neutralizing antibodies in the sample combined with the colloidal gold-labeled SARS-CoV-2 spike protein(SP), then spread to the test area. It is captured by coated SP subunit RBDNTD-CTD, to form a complex and gather in the test area (T line). The quality control area is coated with mouse anti-chicken IgY, and the colloidal goldlabeled chicken IgY is captureed to form a complex and aggregate in hte quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample need to be tested again. |
Spike (SARS-CoV-1) Pseudotyped Lentivirus (eGFP Reporter)-100 µl |
|||
78633-1 | BPS Bioscience | 100 µl | EUR 835 |
Description: Severe acute respiratory syndrome (SARS) was the first new infectious disease identified in the twenty-first century. It is a viral respiratory disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-1). The first known cases occurred in November 2002, and these viral infections led to the 2002-2004 SARS outbreak. Since 2004, no cases of SARS-CoV-1 have been reported worldwide. A virus very similar to SARS-CoV-1 was discovered in late 2019. This virus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the causative pathogen of COVID-19, the spread of which started the COVID-19 pandemic.SARS-CoV-1 attaches to the host cell surface before entering the cell. The Spike protein on the virus recognizes and binds to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of human airway epithelia as well as lung parenchyma. Drugs targeting the interaction between the Spike protein of SARS-CoV-1 and ACE2 may offer protection against the viral infection.The Spike (SARS-CoV-1) Pseudotyped Lentiviruses were produced with SARS-CoV-1 Spike (Genbank Accession #YP_009825051.1) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the eGFP gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be determined via eGFP fluorescence. The Spike (SARS-CoV-1) pseudotyped lentivirus can be used to measure the activity of a neutralizing antibody against SARS-CoV-1 in a cellular context, using a Biosafety Level 2 facility.The Spike (SARS-CoV-1) pseudovirus has been validated for use with ACE2-HEK293 target cells (which overexpress ACE2; BPS Bioscience #79951). |
PLPro, His-tag (SARS-CoV-2) |
|||
100735-1 | BPS Bioscience | 100 µg | EUR 350 |
Description: SARS-Cov-2 papain-like protease (PLPro), part of a large replicase polyprotein 1ab (E1564-Y1882), GenBank Accession No. QHD43415, with a N-terminal His-tag, expressed in an E. coli expression system. MW=38 kDa. |
NSP10/NSP16 Complex (SARS-CoV-2) |
|||
100747-1 | BPS Bioscience | 100 µg | EUR 320 |
Description: Complex of SARS-CoV-2 nonstructural protein 10 (NSP10), GenBank Accession No. YP_009725306.1, a.a. 1-139(full length), with N-terminal FLAG-tag, MW=16 kDa and SARS-CoV-2 nonstructural protein 16 (NSP16), Genbank Accession No. YP_009725311, a.a. 1-298(full length), with N-terminal His-tag, MW=34 kDa, co-expressed in a HEK293 cell expression system. |
NSP7, His-tag (SARS-CoV-2) |
|||
100829-1 | BPS Bioscience | 100 µg | EUR 320 |
Description: SARS-CoV-2 nonstructural protein 7 (NSP7), Genbank Accession No.: YP_009742614, a.a. 1-84(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 10 kDa. |
NSP8, His-tag (SARS-CoV-2) |
|||
100830-1 | BPS Bioscience | 100 µg | EUR 335 |
Description: SARS-CoV-2 nonstructural protein 8 (NSP8), Genbank Accession No.: YP 009725304.1, a.a. 1-198(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 23 kDa. |
ORF9b, GST-Tag (SARS-CoV-2) |
|||
100962-1 | BPS Bioscience | 100 µg | EUR 320 |
Description: Recombinant ORF9b, full length, encompassing amino acids 1-97(end). This recombinant protein corresponds to SARS-CoV-2 accessory protein ORF9b. It was expressed in E.coli and contains an N-terminal GST tag and a prescission protease cleavage site. The recombinant protein is >90% pure following GST affinity purification. |
SARS antibody |
|||
70R-20086 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal SARS antibody |
SARS antibody |
|||
70R-1444 | Fitzgerald | 100 ug | EUR 452.4 |
Description: Rabbit polyclonal SARS antibody raised against the C terminal of SARS |
SARS antibody |
|||
70R-1445 | Fitzgerald | 100 ug | EUR 452.4 |
Description: Rabbit polyclonal SARS antibody raised against the middle region of SARS |
SARS antibody |
|||
39139-100ul | SAB | 100ul | EUR 302.4 |
SARS Antibody |
|||
DF15539 | Affbiotech | 100ul | EUR 420 |
Histone H3K4 Methylation Antibody Panel Pack |
|||
C10005 | EpiGentek |
|
|
Histone H3K9 Methylation Antibody Panel Pack |
|||
C10006 | EpiGentek |
|
|